Reactive changes in ovarian endocrine cells in experimental ischemic damage

The present study is devoted to the morphofunctional substantiation of the model of female hypogonadism, which is important for the subsequent evaluation of the effectiveness of its targeted pharmacological correction, as well as to elucidate the resistance of ovarian endocrine cells to damage as a result of experiencing a single acute ischemic effect. In three groups of adult female rats under anesthesia, the arteries of the right and left ovaries were ligated for 30, 45, and 60 min (4 rats in each group). After the operation, the wound was sutured. Sham-operated rats (4 rats) served as controls. After 7 days, the results were analyzed. The blood levels of sex steroid hormones (17β-estradiol, progesterone) and gonadotropins (FSH and LH) were determined by enzyme-linked immunosorbent assay. In the meridional histological sections of the mature tertiary follicle and the corpus luteum of the right and left ovaries, after survey staining, the number and percentage of viable and dead endocrinocytes were counted, and the area of viable endocrine cells was determined. The significance of differences in the median, upper and lower quartiles of the compared parameters was determined using the nonparametric Mann–Whitney test. It has been established that a single acute ovarian ischemia induces massive death and degenerative changes in a significant part of the viable endocrine cells of the mature tertiary follicle and corpus luteum, most pronounced with a one-hour bilateral occlusion of the ovarian vessels. These quantitative and structural changes in interstitial endocrine cells and ovarian luteocytes cause a significant decrease in the production of sex steroids, which, in turn, causes hyperproduction of the corresponding pituitary tropins. Morphological changes in both types of ovarian endocrine cells in this model of acute single ovarian ischemia are highly sensitive; the use of a number of morphometric parameters of endocrinocytes in combination with the determination of the concentration of peripheral and regulatory homones will allow using this model to assess the effectiveness of the correction of female hypogonadism with various pharmacological preparations.

1. Z.Yu. Chastota besplodiya v brake sredi go-rodskogo i sel'skogo naseleniya Respubliki Buryatiya: rezul'taty populyatsionnogo issledovaniya [The frequency of infertility in marriage among the urban and rural population of the Republic of Buryatia: The results of a population study]. Fundamental'naya i klinicheskaya meditsina — Fundamental and Clinical Medicine, 2017, vol. 2(4), pp. 14–21.

2. Filippov O.S. Prichiny i faktory razvitiya besplodiya sredi naseleniya Sibiri [Causes and factors of infertility development among the population of Siberia]. Epidemiologiya i infektsionnyye bolezni — Epidemiology and Infectious Diseases, 2002, vol. 3, 47 p.

3. Ohtaki T., Shintani Y., Honda S., et al. Nature. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a Gprotein-coupled receptor. Nature, 2001, vol. 411, pp. 613– 617. doi: https://doi.org/10.1038/35079135

4. de Roux N., Genin E., Carel J.C., Matsuda F., Chaussain J.L., Milgrom E. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc. Natl. Acad. Sci. USA, 2003, vol. 100(19), pp. 10972–10976. doi: https://doi.org/10.1073/pnas.1834399100

5. Seminara S.B., Messager S., Chatzidaki E.E., et al. The GPR54 gene as a regulator of puberty. N. Engl. J. Med., 2003, vol. 349, pp. 1614–1627. doi: https://doi.org/10.1056/NEJMoa035322

6. Rukovodstvo po eksperimental'nomu (doklinicheskomu) izucheniyu novykh farmakologicheskikh veshchestv [Guidelines for the experimental (preclinical) study of new pharmacological substances]. Ed. K.U. Khabriyev. Moscow, Izdatel'stvo Meditsina Publ., 2005. 832 p.

7. Freeman, M. E. The ovarian cycle of the rat. Physiology of reproduct. Ed. E.Knobil & J. Nail. New York, Raven Press Ltd., 1988, pp. 1893–1928.

8. Laws S.C., Beggs J.M., Webster J.C., Miller W.L. Inhibin increases, and progesterone decrease receptor for gonadotropinreleasing hormone in ovine pituitary cultures. Endocrinology, 1990, vol. 127(1), pp. 373–380. doi:10.1210/endo-127-1-373

9. Quinones-Jenab V., Jenab S., Ogawa S., Funabashi T., Weesner G.D., Pfaff D.W. Estrogen regulation of gonadotropin-releasing hormone receptor messenger RNA in female rat pituitary tissue. Mol. Brain Res., 1996, vol. 38(2), pp. 243–250. doi: 10.1016/0169-328x(95)00322-j